The biological clock has long been a central theme in discussions regarding maternal health and fertility, but a groundbreaking pair…
Read More
Moderna bets on mRNA’s second act with cancer, autoimmune programs and AI research platform
Moderna, the biotechnology firm that gained global prominence for its mRNA-based COVID-19 vaccine, is embarking on a significant strategic pivot,…
Read More
Bioengineered Human Bone Marrow-on-a-Chip Revolutionizes Drug Testing and Space Medicine Research
In a landmark achievement for bioengineering and regenerative medicine, a collaborative team of researchers from the University of Pennsylvania School…
Read More
Ludwig Cancer Research Study Identifies Novel Combination Therapy to Overcome Differentiation Block in Acute Myelogenous Leukemia
Acute Myelogenous Leukemia (AML) remains one of the most formidable challenges in modern oncology, characterized by a rapid progression and…
Read More
Weedkiller Glyphosate May Be Fueling the Global Antimicrobial Resistance Crisis, New Research Suggests.
A groundbreaking study has unveiled a concerning potential link between glyphosate, the world’s most widely used herbicide, and the escalating…
Read More
Virginia Tech Research Challenges Long Standing Assumptions in Cerebellar Movement Disorder Studies
New research emerging from the Fralin Biomedical Research Institute at VTC is fundamentally questioning the established framework used to study…
Read More
Breakthrough in Rare Kidney Cancer Research Reveals How Gene Fusions Drive Tumor Progression via Liquid Condensates
In a significant advancement for the field of molecular oncology, a multi-disciplinary team of investigators from the Johns Hopkins Kimmel…
Read More
Glioblastoma Research Reveals Skull Erosion and Immune System Reprogramming Reshaping Treatment Strategies
The medical community has long viewed glioblastoma multiforme (GBM) as a localized, albeit highly aggressive, malignancy confined within the blood-brain…
Read More
Biogen Pauses or Terminates Investment in Most of Apellis’ Legacy Research Programs Following $5.6 Billion Acquisition
Three months after Biogen finalized its substantial $5.6 billion acquisition of Apellis Pharmaceuticals, a significant shift in research and development…
Read More
Scientists Replicate Human Bone Marrow Architecture Using Stem Cell Technology to Advance Blood Cancer Research and Reduce Animal Testing
In a landmark achievement for regenerative medicine and hematology, researchers from the University of Basel and University Hospital Basel have…
Read MoreYOU MAY HAVE MISSED
